Direct-acting Antivirals and Hepatocellular Carcinoma Recurrence

NCT03197155 · clinicaltrials.gov ↗

COMPLETED

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma
Hepatitis C
Direct Acting Antivirals

Interventions

DRUG: Direct Acting Antivirals against hepatitis C virus infection

Sponsor

Hospices Civils de Lyon